4
Changes in Ownership
Lexaria Bioscience Corp. Filed Acc 0001103780-15-000032
CEO bought 35,000 shares at an average $0.17 ($5,879)
From the SEC's structured data for this filing
Trades in this filing
BUNKA CHRISTOPHER · CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2015-07-14 | Purchase : show line 1 in the form | +15,000 | $0.16 | $2,400 | 4,501,580 | D |
| 2015-07-14 | Purchase : show line 2 in the form | +5,000 | $0.18 | $900 | 4,506,580 | D |
| 2015-07-15 | Purchase : show line 3 in the form | +15,000 | $0.17 | $2,579 | 4,521,580 | D |
| Open-market purchases · 35,000 sh · avg $0.17 · $5,879 | ||||||
Loading xslF345X03/primary_doc.xml…